90 related articles for article (PubMed ID: 9272408)
1. Ketotifen pharmacokinetics in children with atopic perennial asthma.
McFadyen ML; Miller R; Ludden TM
Eur J Clin Pharmacol; 1997; 52(5):383-6. PubMed ID: 9272408
[TBL] [Abstract][Full Text] [Related]
2. Ketotifen in the young asthmatic--a double-blind placebo-controlled trial.
White MP; MacDonald TH; Garg RA
J Int Med Res; 1988; 16(2):107-13. PubMed ID: 3288523
[TBL] [Abstract][Full Text] [Related]
3. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders.
Grant SM; Goa KL; Fitton A; Sorkin EM
Drugs; 1990 Sep; 40(3):412-48. PubMed ID: 2226222
[TBL] [Abstract][Full Text] [Related]
4. Ketotifen for asthma in children aged 5 to 15 years: a randomized placebo-controlled trial.
Kabra SK; Pandey RM; Singh R; Seth V
Ann Allergy Asthma Immunol; 2000 Jul; 85(1):46-52. PubMed ID: 10923604
[TBL] [Abstract][Full Text] [Related]
5. The determination of pharmacokinetic parameters of ketotifen in steady state in young children.
Schmidt-Redemann B; Brenneisen P; Schmidt-Redemann W; Gonda S
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):496-8. PubMed ID: 3781684
[TBL] [Abstract][Full Text] [Related]
6. Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC study.
Hussein Z; Pitsiu M; Majid O; Aarons L; de Longueville M; Stockis A;
Br J Clin Pharmacol; 2005 Jan; 59(1):28-37. PubMed ID: 15606437
[TBL] [Abstract][Full Text] [Related]
7. Prevention of recurrent wheezing in young children by loratadine compared with ketotifen.
Ngamphaiboon J; Wirawarn T; Thongkaew T
J Med Assoc Thai; 2009 Mar; 92(3):351-5. PubMed ID: 19301727
[TBL] [Abstract][Full Text] [Related]
8. Prevention of asthma by ketotifen in infants with atopic dermatitis.
Iikura Y; Naspitz CK; Mikawa H; Talaricoficho S; Baba M; Sole D; Nishima S
Ann Allergy; 1992 Mar; 68(3):233-6. PubMed ID: 1546818
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of asthma with ketotifen in children and adolescents: a review.
Craps L
Pharmatherapeutica; 1983; 3(5):314-26. PubMed ID: 6405397
[TBL] [Abstract][Full Text] [Related]
10. [A double blind study of the effectiveness of ketotifen in preventing the development of asthma in atopic dermatitis patients].
Iikura Y; Baba M; Mikawa H; Nishima S; Maeda K; Akasaka T; Masaki T; Arita M; Niiya H; Koya N
Arerugi; 1991 Feb; 40(2):132-40. PubMed ID: 2069512
[TBL] [Abstract][Full Text] [Related]
11. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
12. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies on the protective effects of Ketotifen and Intal in atopic asthmatic patients.
Románski B; Pawlik-Miskiewicz K; Wilewska-Klubo T
Allergol Immunopathol (Madr); 1983; 11(1):34-9. PubMed ID: 6407291
[TBL] [Abstract][Full Text] [Related]
14. Ketotifen versus inhaled budesonide for controlling childhood asthma.
Tantichaiyakul P; Preutthipan A
J Med Assoc Thai; 2010 May; 93(5):541-9. PubMed ID: 20524439
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of pranlukast hydrate dry syrup in children with allergic rhinitis and bronchial asthma.
Nakade S; Ueda S; Ohno T; Nakayama K; Miyata Y; Yukawa E; Higuchi S
Drug Metab Pharmacokinet; 2006 Apr; 21(2):133-9. PubMed ID: 16702733
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a new orally active anti-anaphylactic compound: ketotifen (HC 20-511) in Japanese adult asthmatics.
Kumagai A; Tomioka H; Shida T; Takahashi T; Muranaka M
Schweiz Med Wochenschr; 1980 Feb; 110(6):197-203. PubMed ID: 6769159
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ketotifen in young children with asthma.
Volovitz B; Varsano I; Cumella JC; Jaber L
J Allergy Clin Immunol; 1988 Mar; 81(3):526-30. PubMed ID: 3279095
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect and pharmacokinetics of ketotifen transdermal delivery system.
Chiang CH; Chen JL; Liu YT; Wang DP
Drug Dev Ind Pharm; 1998 Mar; 24(3):213-7. PubMed ID: 9876577
[TBL] [Abstract][Full Text] [Related]
19. Regulation of stromal cell-derived factor-1 and exhaled nitric oxide in asthmatic children following montelukast and ketotifen treatment.
Hung CH; Jong YJ; Hua YM; Li CY; Lai YS; Yang KD; Chang HC
Pulm Pharmacol Ther; 2007; 20(3):233-9. PubMed ID: 17276712
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of Ketotifen in Nepalese asthmatic children: a clinical study.
Shakya KN; Joshi P; Piya A; Baral MR
Kathmandu Univ Med J (KUMJ); 2003; 1(4):242-7. PubMed ID: 16388263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
